Healthcare provider profile · identity verified

Seth Patrick Vining, MD

Internal Medicine · INDIAN LAND, SC · NPI 1477991479

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	715	197
Amlodipine Besylate	Amlodipine Besylate	469	131
Levothyroxine Sodium	Levothyroxine Sodium	432	107
Omeprazole	Omeprazole	279	79
Losartan Potassium	Losartan Potassium	268	69
Lisinopril	Lisinopril	246	62
Simvastatin	Simvastatin	241	63
Rosuvastatin Calcium	Rosuvastatin Calcium	186	54
Hydrochlorothiazide	Hydrochlorothiazide	169	48
Metformin Hcl	Metformin Hcl	157	45
Tamsulosin Hcl	Tamsulosin Hcl	157	47
Pantoprazole Sodium	Pantoprazole Sodium	156	45
Sertraline Hcl	Sertraline Hcl	144	39
Metoprolol Succinate	Metoprolol Succinate	133	42
Trazodone Hcl	Trazodone Hcl	133	37
Gabapentin	Gabapentin	112	37
Metformin Hcl Er	Metformin Hcl	99	28
Eliquis	Apixaban	98	24
Meloxicam	Meloxicam	98	28
Finasteride	Finasteride	97	24
Pravastatin Sodium	Pravastatin Sodium	90	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	77	21
Citalopram Hbr	Citalopram Hydrobromide	68	19
Alendronate Sodium	Alendronate Sodium	67	23
Donepezil Hcl	Donepezil Hcl	67	16
Duloxetine Hcl	Duloxetine Hcl	67	14
Allopurinol	Allopurinol	66	19
Synthroid	Levothyroxine Sodium	64	16
Chlorthalidone	Chlorthalidone	61	23
Bupropion Xl	Bupropion Hcl	60	18
Spironolactone	Spironolactone	60	16
Furosemide	Furosemide	59	22
Atenolol	Atenolol	58	15
Escitalopram Oxalate	Escitalopram Oxalate	58	19
Potassium Chloride	Potassium Chloride	57	19
Propranolol Hcl	Propranolol Hcl	57	19
Jardiance	Empagliflozin	56	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	16
Carvedilol	Carvedilol	50	16
Ropinirole Hcl	Ropinirole Hcl	50	suppressed
Clopidogrel	Clopidogrel Bisulfate	49	13
Glipizide Er	Glipizide	48	suppressed
Montelukast Sodium	Montelukast Sodium	47	15
Telmisartan	Telmisartan	47	13
Irbesartan	Irbesartan	46	12
Valsartan	Valsartan	45	11
Pioglitazone Hcl	Pioglitazone Hcl	43	suppressed
Glimepiride	Glimepiride	42	suppressed
Trulicity	Dulaglutide	42	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	40	11
Ezetimibe	Ezetimibe	38	suppressed
Famotidine	Famotidine	38	13
Esomeprazole Magnesium	Esomeprazole Magnesium	36	suppressed
Prednisone	Prednisone	36	32
Ramipril	Ramipril	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	31
Fluticasone Propionate	Fluticasone Propionate	33	17
Metoprolol Tartrate	Metoprolol Tartrate	33	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	32	20
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Promethazine Hcl	Promethazine Hcl	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	13
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	21
Valacyclovir	Valacyclovir Hcl	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Azithromycin	Azithromycin	24	22
Januvia	Sitagliptin Phosphate	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Torsemide	Torsemide	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Glipizide	Glipizide	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Myrbetriq	Mirabegron	17	suppressed
Testosterone	Testosterone	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Cephalexin	Cephalexin	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	16
Alprazolam	Alprazolam	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	15	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Ranolazine Er	Ranolazine	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Naproxen	Naproxen	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	11
Trospium Chloride Er	Trospium Chloride	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Cefdinir	Cefdinir	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error